TMCnet News
Global Thrombocythaemia Myelofibrosis Pipeline Review 2016 - Research and MarketsResearch and Markets has announced the addition of the "Thrombocythaemia Myelofibrosis - Pipeline Review, H2 2016" drug pipelines to their offering. This report provides comprehensive information on the therapeutic development for Thrombocythaemia Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombocythaemia Myelofibrosis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Key Topics Covered:
For more information about this drug pipelines visit http://www.researchandmarkets.com/research/6pgc36/thrombocythaemia Related Topics: Leukemia Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160825006086/en/ |
